Respiratory muscle aids for the prevention of pulmonary morbidity and mortality

Research output: Contribution to journalReview article

16 Citations (Scopus)

Abstract

The great majority of individuals with ventilatory failure due to paralytic syndromes can be managed entirely by noninvasive inspiratory and expiratory muscle aids. When the equipment is properly used, individuals may eventually become dependent on noninvasive IPPV 24 hours a day without ever being hospitalized, intubated, tracheostomized, or bronchoscoped. The use of noninvasive respiratory muscle aids eliminates the need for 'crisis' decision making about whether or not to 'go on a respirator. Use of respiratory muscle aids by ALS patients familiarizes them with ventilator dependency before any decision about tracheostomy needs to be made. These methods enhance quality of life in many ways, including permitting the use of GPB for security in the event of ventilator failure. They can also drastically decrease cost and optimize psychosocial functioning. These techniques should become part of the therapeutic armamentarium of every physician who treats patients with generalized neuromuscular disorders who have the potential to develop ventilatory insufficiency, mucus plugging, or both.

Original languageEnglish (US)
Pages (from-to)72-83
Number of pages12
JournalSeminars in neurology
Volume15
Issue number1
DOIs
StatePublished - Jan 1 1995
Externally publishedYes

Fingerprint

Respiratory Muscles
Mechanical Ventilators
Morbidity
Lung
Mortality
Intermittent Positive-Pressure Ventilation
Tracheostomy
Mucus
Decision Making
Quality of Life
Physicians
Costs and Cost Analysis
Equipment and Supplies
Muscles
Therapeutics

All Science Journal Classification (ASJC) codes

  • Clinical Neurology
  • Neurology

Cite this

@article{35eba34b4e534710a7519481a0ddd60d,
title = "Respiratory muscle aids for the prevention of pulmonary morbidity and mortality",
abstract = "The great majority of individuals with ventilatory failure due to paralytic syndromes can be managed entirely by noninvasive inspiratory and expiratory muscle aids. When the equipment is properly used, individuals may eventually become dependent on noninvasive IPPV 24 hours a day without ever being hospitalized, intubated, tracheostomized, or bronchoscoped. The use of noninvasive respiratory muscle aids eliminates the need for 'crisis' decision making about whether or not to 'go on a respirator. Use of respiratory muscle aids by ALS patients familiarizes them with ventilator dependency before any decision about tracheostomy needs to be made. These methods enhance quality of life in many ways, including permitting the use of GPB for security in the event of ventilator failure. They can also drastically decrease cost and optimize psychosocial functioning. These techniques should become part of the therapeutic armamentarium of every physician who treats patients with generalized neuromuscular disorders who have the potential to develop ventilatory insufficiency, mucus plugging, or both.",
author = "John Bach",
year = "1995",
month = "1",
day = "1",
doi = "https://doi.org/10.1055/s-2008-1041010",
language = "English (US)",
volume = "15",
pages = "72--83",
journal = "Seminars in Neurology",
issn = "0271-8235",
publisher = "Thieme Medical Publishers",
number = "1",

}

Respiratory muscle aids for the prevention of pulmonary morbidity and mortality. / Bach, John.

In: Seminars in neurology, Vol. 15, No. 1, 01.01.1995, p. 72-83.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Respiratory muscle aids for the prevention of pulmonary morbidity and mortality

AU - Bach, John

PY - 1995/1/1

Y1 - 1995/1/1

N2 - The great majority of individuals with ventilatory failure due to paralytic syndromes can be managed entirely by noninvasive inspiratory and expiratory muscle aids. When the equipment is properly used, individuals may eventually become dependent on noninvasive IPPV 24 hours a day without ever being hospitalized, intubated, tracheostomized, or bronchoscoped. The use of noninvasive respiratory muscle aids eliminates the need for 'crisis' decision making about whether or not to 'go on a respirator. Use of respiratory muscle aids by ALS patients familiarizes them with ventilator dependency before any decision about tracheostomy needs to be made. These methods enhance quality of life in many ways, including permitting the use of GPB for security in the event of ventilator failure. They can also drastically decrease cost and optimize psychosocial functioning. These techniques should become part of the therapeutic armamentarium of every physician who treats patients with generalized neuromuscular disorders who have the potential to develop ventilatory insufficiency, mucus plugging, or both.

AB - The great majority of individuals with ventilatory failure due to paralytic syndromes can be managed entirely by noninvasive inspiratory and expiratory muscle aids. When the equipment is properly used, individuals may eventually become dependent on noninvasive IPPV 24 hours a day without ever being hospitalized, intubated, tracheostomized, or bronchoscoped. The use of noninvasive respiratory muscle aids eliminates the need for 'crisis' decision making about whether or not to 'go on a respirator. Use of respiratory muscle aids by ALS patients familiarizes them with ventilator dependency before any decision about tracheostomy needs to be made. These methods enhance quality of life in many ways, including permitting the use of GPB for security in the event of ventilator failure. They can also drastically decrease cost and optimize psychosocial functioning. These techniques should become part of the therapeutic armamentarium of every physician who treats patients with generalized neuromuscular disorders who have the potential to develop ventilatory insufficiency, mucus plugging, or both.

UR - http://www.scopus.com/inward/record.url?scp=0029071757&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029071757&partnerID=8YFLogxK

U2 - https://doi.org/10.1055/s-2008-1041010

DO - https://doi.org/10.1055/s-2008-1041010

M3 - Review article

C2 - 7638462

VL - 15

SP - 72

EP - 83

JO - Seminars in Neurology

JF - Seminars in Neurology

SN - 0271-8235

IS - 1

ER -